Navigation Links
UIC to serve as Chicago site for largest-ever US study of Hispanic/Latino health
Date:7/8/2013

The University of Illinois at Chicago Institute for Minority Health Research will manage a National Institutes of Health project to follow up, over the next six years, all Chicago participants in the Hispanic Community Health Study/Study of Latinosthe largest-ever prospective health study of this population.

The NIH contract to be managed by UIC is for up to $15.3 million.

"The Hispanic/Latino population is growing faster than any other minority group in the U.S., and to better serve their health needs, we need to know where they stand as a wholethis study lets us see that big picture," says Dr. Martha Daviglus, director of the UIC Institute for Minority Health Research and principal investigator of the Chicago field center.

The multi-center, prospective, population-based study includes more than 16,400 Hispanic/Latino adults between the ages of 18 and 74. Participants are of diverse backgroundsincluding Cuban, Dominican, Mexican, Puerto Rican, Central American, and South Americanand have been recruited from four U.S. communities.

The first phase of the study, from 2008 through 2012, collected baseline health data on participants.

In the second phase, researchers will reexamine the participants and collect data on chronic diseases that are prevalent in Hispanics/Latinos, including heart disease, diabetes, asthma, chronic obstructive pulmonary disease and gestational diabetes.

The second examination will include assessment of cardiovascular risk factors, echocardiography, and blood and urine tests. Participants will complete a questionnaire on demographic, sociocultural, and lifestyle factors. Genetic information will be analyzed to determine if health and disease findings can be linked to specific gene variants.

The original study revealed a startling burden of risk among the Hispanic/Latino population.

"We found that 80 percent of men and 71 percent of women have at least one adverse risk
'/>"/>

Contact: Sharon Parmet
sparmet@uic.edu
312-413-2695
University of Illinois at Chicago
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Satellite observes rapid ice shelf disintegration in Antarctic
2. Protein prevents DNA damage in the developing brain and might serve as a tumor suppressor
3. Eating Berries Might Help Preserve Your Memory
4. GSW Telnet Server for Windows Partners with MobileDemand
5. Ovarian Transplants May Preserve Fertility in Young Cancer Survivors
6. Multiple husbands serve as child support and life insurance in some cultures says MU researcher
7. People More Likely to Guzzle Beer Served in Curved Glasses
8. Case Western Reserve researchers create short-term memories in-vitro
9. Proton therapy treatment preserves quality of life for men with prostate cancer
10. New Yorks Medical Schools urge Congress to preserve NIH funding for scientific research
11. Mesothelioma Victims Center Now Fears Most US Victims of Mesothelioma get Less Compensation than They Deserve So They Offer the Names of the Best Mesothelioma Law Firms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Volunteers from the Church of Scientology of Denmark ... with massive distribution of Truth About Drugs ... on Strøget, the famous Copenhagen walking street. Popular ... its ambiance, some quarter of a million people stroll ... , These activities are part of a coordinating effort ...
(Date:7/30/2014)... fuel cancer as well as evolutionary changes in a ... occur randomly throughout the genome. , However, recent studies ... of multiple mutations that arise simultaneously and in close ... are frequently found in regions where chromosomal rearrangements take ... Cell Reports , may one day lead to new ...
(Date:7/30/2014)... MA (PRWEB) July 30, 2014 ... of authentication, access management and secure communications solutions ... Imprivata OneSign ® is the most widely selected ... McKesson Paragon or Horizon electronic medical records (EMR) ... increase of about 11 percent in the last ...
(Date:7/30/2014)... Hamilton Facial Plastic Surgery is happy ... on July 30th. After months of planning, Dr. Hamilton ... state-of-the-art suite, located only steps away from the original ... one-on-one patient comfort, shorter wait times, and generally a ... new office-suite will continue to provide the same wide ...
(Date:7/30/2014)... (July 30, 2014) The phrase "we caught it early" ... in the midst of a cancer diagnosis. Combating cancer ... to a certain part of the body, gives patients ... breast, skin, colon, prostate and other forms of cancer ... health care providers recommend cancer screenings as a precautionary ...
Breaking Medicine News(10 mins):Health News:Biologists describe mechanism promoting multiple DNA mutations 2Health News:Imprivata Achieves 51 Percent Single Sign-on Market Share Amongst U.S. Hospitals Using McKesson Paragon or Horizon EMR Systems, According to HIMSS Analytics 2Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 3
... OAKLAND, Calif., Aug. 11 The American Heart ... Oakland and,Stanford University Medical Center $3.89 million over ... heart research center that aims to define,optimal clinical ... chronic,heart failure., The Kaiser Permanente Division of ...
... Aug. 11 Perrigo Company,(Nasdaq: PRGO ; ... chewable tablets (famotidine 10 mg; calcium carbonate 800mg;,magnesium ... under their store,brand labels. Perrigo won a successful ... to Pepcid Complete(R) marketed by,Johnson & Johnson - ...
... Inc., a,global leading manufacturer of orthodontic products and ... a full-service,orthodontic laboratory. The O2 Orthodontic Laboratory is ... Carlsbad, CA., "The O2 Orthodontic Laboratory is ... it allows the Company to further its,commitment to ...
... (GICD) and UCSF have identified a key regulatory factor ... the extensive network of arteries, veins, and capillaries that ... research, published in the latest issue of Developmental ... for a wide variety of diseases, such as heart ...
... examinations of PSA screening in younger men, a study published ... of men under age 50 reported undergoing a prostate specific ... year, yet only one in three young black men reported ... , Overall, that,s pretty good news for white men at ...
... chemical might lead to drug treatments for humans , , SUNDAY, ... of mice resistant to diet-induced obesity. , The findings ... in people. They also shed light on the brain circuitry ... energy (i.e., food) an animal takes in and how quickly ...
Cached Medicine News:Health News:Kaiser Permanente - Stanford Heart Research Center Funded to Study Treatment Outcomes 2Health News:Kaiser Permanente - Stanford Heart Research Center Funded to Study Treatment Outcomes 3Health News:Kaiser Permanente - Stanford Heart Research Center Funded to Study Treatment Outcomes 4Health News:Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide 2Health News:Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide 3Health News:Ortho Organizers(R) Opens a Full-Service Orthodontic Laboratory 2Health News:Gladstone scientists identify single microRNA that controls blood vessel development 2Health News:Gladstone scientists identify single microRNA that controls blood vessel development 3Health News:Study finds more PSA screening awareness needed among high-risk groups 2Health News:Scientists Create Mice Resistant to Obesity 2Health News:Scientists Create Mice Resistant to Obesity 3
(Date:7/30/2014)... 2014 Cynosure, Inc. (NASDAQ: ... for non-invasive and minimally invasive applications, today announced that the ... Officer and Chief Financial Officer Timothy W. Baker ... 53, will continue to serve as CFO and will take ... remains Chairman and Chief Executive Officer. "Tim ...
(Date:7/30/2014)... CLARA, Calif. , July 30, 2014 ... economy, released a study today that examines ... biopharma and medical device companies.  According to the annual ... saw the biggest potential returns since SVB started tracking ... year of the IPO.  Built on solid healthcare M&A ...
(Date:7/30/2014)... WOODCLIFF LAKE, N.J. and SAN DIEGO ... Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today that ... Phase 3 trials of lorcaserin entitled, "Early Weight Loss While ... 52 Weight-Loss Outcomes," was recently published in the online issue ... The Obesity Society. The objective of these analyses was to ...
Breaking Medicine Technology:Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7
... , SALT LAKE CITY, Dec. 16 ... "Company"), a medical device company engaged in the development and ... that Joe Pepper, PhD, has been appointed to the TechniScan ... "Joe has extensive experience running small to large medical devices ...
... EVANSTON, Ill., Dec. 16 Naurex Inc., a new clinical ... disorders based on its novel GFPA NMDA receptor modulators, today ... of its lead compound GLYX-13 and has successfully dosed the ... functional partial agonist (GFPA) selective modulator of the NMDA receptor, ...
Cached Medicine Technology:In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 2In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 3Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3
... K-ASSAY ASO / RF / ... to be used as a ... concentration for monitoring the performance ... Rheumatoid Factor (RF), and C-Reactive ...
... of benchtop microcentrifuges with the 5424. ... aerosol-tight rotor and a unique, contoured ... ,Model 5424 expands its application range ... microcentrifuge tubes, miniprep spin columns and ...
... hand, the Jarvik 2000 pump is about the ... titanium shell sits a direct-current motor, a rotor ... moving part: a small, spinning titanium impeller that ... 7 liters per minute. Rather than take over ...
... VentrAssist is a new third generation cardiac assist ... heart transplants for patients suffering heart failure., ,It ... left ventricle of the diseased heart to help ... restoring a better quality of life. , ,It ...
Medicine Products: